Abstract:Advances in pediatric and obstetric surgery have resulted in an increase in the duration and complexity of procedures requiring anesthesia. It has been reported that anesthetic drugs cause widespread and dose-dependent apoptosis in the developing rat brain. The similarity of the physiology, pharmacology, metabolism, and reproductive systems of the nonhuman primate to that of the human, especially during pregnancy, make the monkey an exceptionally good animal model for assessing potential neurotoxic effects of anesthetics. The window of vulnerability to these neuronal effects of pediatric anesthetics is restricted to the period of rapid synaptogenesis, also known as the brain growth spurt period. To minimize the risks to children resulting from the use of anesthesia, the following questions should be addressed: 1. What is the relationship between exposure and brain cell loss for drugs commonly used in the practice of pediatric anesthesia (inhaled anesthetics, midazolam, ketamine, and nitrous oxide)? 2. Are there "class effects," or does each drug need to be considered independently? 3. Are there important interactions among the drugs used as anesthetics contributing to the risk of brain cell death? 4. What is the likely period of human vulnerability? Pharmacogenomic/system biology approaches have great potential for helping to advance the understanding of brain-related biological processes, including neuronal plasticity and neurotoxicity. Because of the complexity and temporal features of how developmental neurotoxicity is manifested, pharmacogenomic/systems biology approaches may prove to be useful tools for enhancing our understanding of the biological processes induced by anesthetics. Therefore, the main purpose of this review is to describe the application of these approaches and models, as well as protection strategies, especially as regards the issue of anesthetic-induced neuronal cell death during development. Much of the discussion that follows is based on experiments conducted with ketamine. This is due in part to the use of ketamine in the early studies and the volume of preclinical experimental work performed with this drug, as well as its use in anesthetic studies in developing rodents and nonhuman primates. Although ketamine use in pediatric anesthesia is relatively limited, the findings of the studies are sufficiently strong to merit concern about the N-methyl-d-aspartate antagonist drugs as a class. Our focus on ketamine should not be construed as implying that the risk of neurodegeneration with ketamine is greater, or less, than with other anesthetics. We are simply describing the effects where we have the most preclinical data.

MicroRNAs: New Players in Anesthetic-Induced Developmental Neurotoxicity.

Microrna 218 Modulates Pkc/Akt Pathway To Protect Lidocaine-Induced Neurotoxicity In Ganglia In Vitro

Signaling network between the dysregulated expression of microRNAs and mRNAs in propofol-induced developmental neurotoxicity in mice

Modeling Anesthetic Developmental Neurotoxicity Using Human Stem Cells

Recent Insights Into Molecular Mechanisms of Propofol-induced Developmental Neurotoxicity: Implications for the Protective Strategies

Mechanistic insights into neurotoxicity induced by anesthetics in the developing brain.

Down-regulation of microRNA-21 is involved in the propofol-induced neurotoxicity observed in human stem cell-derived neurons.

Neuroinflammation in the Developing Brain: Risk Factors, Involvement of Microglial Cells, and Implication for Early Anesthesia

Effect and mechanism of general anesthetics induced neurodegeneration in the developing brain

Cellular Mechanisms Associated with Neurodevelopmental Alterations Produced by General Anesthetics

The effects of general anesthetics on mitochondrial structure and function in the developing brain

Neurotoxicity of General Anesthetics in the Developing Brain: Insight into the Glutamate and GABA Receptor Signalling

Identification of Microrna/target Gene in the Dentate Gyrus of 7-Day-old Mice Following Isoflurane Exposure

Altered Hippocampal Microrna Expression Profiles in Neonatal Rats Caused by Sevoflurane Anesthesia: MicroRNA Profiling and Bioinformatics Target Analysis

Abstract 024: MicroRNAs and Anesthetic Cardioprotection in Diabetes

Early Developmental Exposure to General Anesthetic Agents in Primary Neuron Culture Disrupts Synapse Formation Via Actions on the Mtor Pathway

Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits

Strategies and Experimental Models for Evaluating Anesthetics: Effects on the Developing Nervous System

Emerging Model in Anesthetic Developmental Neurotoxicity: Human Stem Cells.

Unraveling the signaling network between dysregulated microRNA and mRNA expression in sevoflurane-induced developmental neurotoxicity in rat

The Role of Mir‐21 in Propofol‐induced Neurotoxicity in Developing Human Neurons (1093.2)